Tim Waterboer Selected Research

Hypertension (High Blood Pressure)

1/2022	Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: results from the KORA cohort.
1/2019	Helicobacter pylori Seropositivity: Prevalence, Associations, and the Impact on Incident Metabolic Diseases/Risk Factors in the Population-Based KORA Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Waterboer Research Topics

Disease

83	Neoplasms (Cancer) 04/2024 - 03/2005
49	Infections 04/2024 - 10/2007
22	Oropharyngeal Neoplasms 03/2024 - 04/2011
22	Papillomavirus Infections 12/2023 - 11/2008
15	Stomach Neoplasms (Stomach Cancer) 01/2023 - 11/2015
15	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 12/2014
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 10/2005
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 10/2007
11	Squamous Cell Carcinoma of Head and Neck 02/2024 - 04/2011
9	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 10/2012
7	Multiple Sclerosis 10/2023 - 02/2016
6	Anus Neoplasms (Anal Cancer) 04/2024 - 03/2015
6	Carcinogenesis 01/2023 - 02/2010
6	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 01/2008
5	Carcinoma (Carcinomatosis) 12/2023 - 04/2011
5	Nasopharyngeal Carcinoma 04/2023 - 11/2019
5	Lung Neoplasms (Lung Cancer) 12/2022 - 07/2014
5	Skin Neoplasms (Skin Cancer) 03/2022 - 11/2008
4	Persistent Infection 11/2022 - 01/2016
3	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2019
3	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2019
3	COVID-19 12/2023 - 01/2021
3	Uterine Cervical Dysplasia 01/2023 - 01/2022
3	Coinfection 03/2022 - 12/2020
3	Epstein-Barr Virus Infections 12/2021 - 01/2020
3	Infectious Mononucleosis (Glandular Fever) 01/2021 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2020 - 02/2011
2	Adenoma (Adenomas) 01/2023 - 01/2017
2	Papilloma (Papillomatosis) 01/2022 - 02/2011
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Glioma (Gliomas) 01/2022 - 05/2021
2	Gastritis 01/2022 - 01/2019
2	Condylomata Acuminata (Genital Wart) 01/2021 - 10/2009
2	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2013
2	Unknown Primary Neoplasms 01/2021 - 01/2018
2	Stomach Diseases 01/2021 - 10/2017
2	Obesity 01/2021 - 01/2021
2	Metrorrhagia (Spotting) 11/2020 - 02/2019
2	Squamous Intraepithelial Lesions 11/2020 - 01/2010
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 01/2019
2	Hepatitis B 01/2020 - 01/2018
2	Testicular Neoplasms (Testicular Cancer) 12/2019 - 12/2019
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2015
2	Herpes Simplex 11/2016 - 09/2012
2	Polyomavirus Infections 10/2016 - 02/2013
1	Hypersensitivity (Allergy) 01/2024
1	Ulcer 12/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2023
1	Extranodal Extension 04/2023

Drug/Important Bio-Agent (IBA)

100	AntibodiesIBA 04/2024 - 10/2005
47	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 03/2005
45	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2008
43	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2009
37	AntigensIBA 01/2024 - 01/2015
13	ORALIT (ORS)IBA 01/2024 - 08/2012
11	Oncogene Proteins (Oncogene Protein)IBA 03/2024 - 10/2005
11	VaccinesIBA 01/2023 - 06/2007
10	Immunoglobulin G (IgG)IBA 04/2023 - 11/2016
7	Immunoglobulin A (IgA)IBA 04/2023 - 01/2019
6	Capsid Proteins (Capsid Protein)IBA 01/2021 - 06/2007
6	ProteomeIBA 01/2021 - 01/2018
5	Messenger RNA (mRNA)IBA 12/2023 - 10/2012
5	Papillomavirus Vaccines (HPV Vaccines)IBA 12/2023 - 01/2016
5	RNA (Ribonucleic Acid)IBA 11/2017 - 07/2014
4	Glutathione Transferase (Glutathione S-Transferase)IBA 04/2024 - 02/2011
4	AutoantibodiesIBA 12/2022 - 01/2016
4	Cytotoxins (Cytolysins)IBA 12/2021 - 06/2020
4	EBV-encoded nuclear antigen 1IBA 12/2021 - 01/2020
3	Neutralizing AntibodiesIBA 12/2023 - 01/2019
3	Contraceptive Agents (Contraceptives)IBA 01/2022 - 01/2016
3	CatalaseIBA 01/2022 - 12/2009
3	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 06/2020
3	Viral DNAIBA 01/2021 - 07/2015
2	CarcinogensIBA 10/2023 - 11/2020
2	ImmunosorbentsIBA 01/2023 - 02/2010
2	EnzymesIBA 01/2023 - 02/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2021
2	Combined VaccinesIBA 10/2021 - 01/2016
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 01/2021
2	Viral AntigensIBA 01/2020 - 10/2018
2	FlagellinIBA 01/2019 - 01/2019
2	AnoctaminsIBA 01/2019 - 02/2016
2	Urea (Carbamide)FDA LinkGeneric 10/2017 - 12/2009
2	Nucleic AcidsIBA 10/2016 - 01/2010
2	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2016 - 10/2012
2	Rituximab (Mabthera)FDA Link 01/2016 - 10/2015
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2015 - 06/2007
1	beta Carotene (Betacarotene)FDA Link 01/2024
1	alpha-Tocopherol FDA Link 01/2024
1	immune RNA (I-RNA)IBA 12/2023
1	Dihydrotachysterol (AT 10)IBA 12/2023
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2023
1	AminesIBA 10/2023
1	latency-associated nuclear antigenIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023

Therapy/Procedure

3	Therapeutics 01/2020 - 06/2010
2	Aftercare (After-Treatment) 01/2020 - 01/2017
2	Organ Transplantation 01/2015 - 02/2013